CoSolve is a biannual, global Open Innovation programme seeking collaborators with innovative solutions to real research challenges. These challenges lie within Astrazeneca'a R&D research focus areas and require solutions that are immediately translatable. We are looking for collaborators from academia, start-ups and early stage biotechs with expertise in these specialised areas, who can bring innovative ideas that can be rapidly translated into tangible solutions. Working together, your ideas could help shape the development and delivery of new therapies and bring them to patients sooner.

Programme details

Submission status: Active

Closing date: 6 March 2024

What are we looking for?

CoSolve is focused on accelerating the development of new therapies for patients with the greatest need. We are looking for innovative solutions that can be translated into practice within a 12–18-month timeframe.

Benefits

CoSolve will give you access to our knowledge and resources, helping develop your ideas into possible future advances in life-changing medicines. You will be working side-by-side with some of our top experts across our R&D focus areas and drug discovery and development.

Who are we looking for?

We are seeking collaborators, ideally from academia, start-ups and early-stage biotech companies, with expertise to address specific CoSolve challenges. Successful collaborators must have the ability and freedom of operation to accelerate their idea into a fully translatable, tangible solution with support from AstraZeneca.

How to apply

Submit your proposal before the deadline by clicking on the challenges listed below

For questions or inquiries please fill in the contact form found here